Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Supiot

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Specificities of clinical research in radiotherapyC Hennequin, D Azria, P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 7, 2014
Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?G Créhange, M Roach, E Martin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 14, 2024
[Does radiation therapy for prostate cancer increase the risk of second cancers?]A Boué-Raflé, A Briens, S Supiot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 27, 2021
External radiotherapy for prostatic cancersR de Crevoisier, S Supiot, G Créhange, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2022
Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFITK Zhou, M Renouf, G Perrocheau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 5, 2023
[Stereotactic body radiation therapy for primary kidney cancer]L Abancourt, J Le Guévelou, A Taillez, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 9, 2023
Insights on the carbon footprint of radiotherapy in FranceM Piffoux, G Delpon, C Ducrot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2018
[Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases]I Barillot, D Antoni, J Bellec, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 14, 2023
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?J F Py, J Salleron, G Vogin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 11, 2006
Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancerS Supiot, J Bennouna, E Rio, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 26, 2021
Specificities of clinical research in radiotherapyC Hennequin, D Azria, P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 7, 2014
Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?G Créhange, M Roach, E Martin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 14, 2024
[Does radiation therapy for prostate cancer increase the risk of second cancers?]A Boué-Raflé, A Briens, S Supiot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 27, 2021
External radiotherapy for prostatic cancersR de Crevoisier, S Supiot, G Créhange, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2022
Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFITK Zhou, M Renouf, G Perrocheau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 5, 2023
[Stereotactic body radiation therapy for primary kidney cancer]L Abancourt, J Le Guévelou, A Taillez, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 9, 2023
Insights on the carbon footprint of radiotherapy in FranceM Piffoux, G Delpon, C Ducrot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2018
[Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases]I Barillot, D Antoni, J Bellec, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 14, 2023
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?J F Py, J Salleron, G Vogin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 11, 2006
Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancerS Supiot, J Bennouna, E Rio, et al.
Pageof 8